HBPCF (Helix BioPharma) Institutional Ownership: 0.00% (As of Jul. 04, 2026)


HBPCF Helix BioPharma Corp HBPCF
28 GF Score
Price $1.71
View Full Analysis

What is Helix BioPharma Institutional Ownership?

Helix BioPharma HBPCF 28 Institutional Ownership is 0.00% as of Jul. 04, 2026. GuruFocus rates HBPCF with a GF Score™ of 28/100.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Helix BioPharma's institutional ownership is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Helix BioPharma's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Helix BioPharma's Float Percentage Of Total Shares Outstanding is 95.45%.

Helix BioPharma Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Helix BioPharma's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Helix BioPharma Institutional Ownership Chart

Helix BioPharma Historical Data

The historical data trend for Helix BioPharma can be seen below:

2012-12-31 2013-01-31 2013-02-28 2013-03-31 2013-04-30 2013-05-31 2013-06-30 2013-07-31 2013-08-31 2013-09-30
Institutional Ownership 0.03 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02
HBPCF
28GF Score
Helix BioPharma Corp HBPCF
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Helix BioPharma Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 0.00% mean?
Helix BioPharma (HBPCF) has a Institutional Ownership of 0.00% as of Jul. 04, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Helix BioPharma and its competitors.
Is Helix BioPharma's Institutional Ownership too high?
Helix BioPharma's current Institutional Ownership is 0.00%. Overall, Helix BioPharma has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Helix BioPharma's Institutional Ownership compare to VRTX and REGN?
Helix BioPharma's Institutional Ownership of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Helix BioPharma and its competitors. Helix BioPharma's current Institutional Ownership is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Helix BioPharma stock overvalued right now?
Helix BioPharma (HBPCF) has a current Institutional Ownership of 0.00%. The current Institutional Ownership is 0.00%. Helix BioPharma's overall GF Score™ is 28/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Helix BioPharma (HBPCF), the current Institutional Ownership is 0.00% as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Helix BioPharma Business Description

Other Exchanges HBP0:GermanyHBP:Canada
Address 40 Temperance Street, Suite 2700, Bay Adelaide Centre - North Tower, Toronto, ON, CAN, M5H0B4
Helix BioPharma Corp is a clinical-stage biopharmaceutical company developing therapies in immune-oncology focused on cancer prevention and treatment. The Company is developing a proprietary platform of bio-conjugates targeting hard-to-treat solid tumors over-expressing CEACAM6, including Tumor Defense Breaker, L-DOS47, and three CEACAM6-specific antibody-drug conjugates. Its pre-IND candidates include LEUMUNA, an oral immune checkpoint modulator for hematological malignancies, and GEMCEDA, an oral prodrug of gemcitabine for solid tumors.
28GF Score

Get the complete analysis for HBPCF

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.71
Price